New York Times, September 22,2009

While reading the New York Times the stories on the front page did not really catch my eye today. The stories were interesting and even though in some way they did pertain to me, I had little interest in reading them further. The only article that I read fully was about how the healthier banks may be bailing out failing banks instead of the government. As I skimmed through the front page, I read the titles of stories at the bottom that direct you to other sections of the newspaper. One story that caught my eye was the story on the H1N1 vaccine.
I found the story particularly interesting because since the second wave of the H1N1 came it is said to be stronger and affect more people. Being at a college campus where the flu, mono and colds circulate even faster then normal, the H1N1 virus would spread here very fast. This made me interested in the article explaining a little about the vaccine. I had heard that the vaccine may have negative side effects in the future. I learned that the adjuvant added to the vaccine are what is unknown to scientist and the effects are also unknown. Adjuvant is not put into the vaccine in the United States because of that. Other countries that use adjuvant in their vaccine put it in because it makes the shot four times more affective. The shot therefore can be used and given to more people, therefore countries with high populations and less money to buy and produce the vaccine will be adding them to their shots. I thought that this was interesting because I heard on the H1N1 shot becoming available at UNH and didn’t know anything about it or it’s side effects. This article is going to make me look further into the vaccine and what it can do for me.